...
Shield Therapeutics PLC 24 April 2025 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Audited results for the year...
Shield Therapeutics PLC on Tuesday reported an exclusive deal with a Japanese distributor, as it looks keep expanding ...
Shield Therapeutics PLC 22 April 2025 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Licence Agreement in Japan for...
The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by ...
Shield Therapeutics PLC 17 April 2025 The information contained within this announcement is deemed by the Company to constitute inside...
Shield Therapeutics PLC 11 March 2025 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") ACCRUFeR® launched in Canada...
Shield Therapeutics PLC 13 February 2025 Shield Therapeutics plc ("Shield Therapeutics" or the "Company") PDMR Transaction Notification ...
Shield Therapeutics PLC 13 February 2025 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Grant of Share Options London...
Shield Therapeutics PLC shares jumped on Wednesday as its revenue soared in 2024 and it said it expects to be cash fl ...
Shield Therapeutics PLC 05 February 2025 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Unaudited full year trading...
The following is a round-up of London-listed company director and manager changes announced in the past week and not ...
Shield Therapeutics PLC 27 January 2025 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Anders Lundstrom appointed CEO ...
Support
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads